[go: up one dir, main page]

AU2001278558A1 - Use of co for treating inflammation of upper airways or bronchi - Google Patents

Use of co for treating inflammation of upper airways or bronchi

Info

Publication number
AU2001278558A1
AU2001278558A1 AU2001278558A AU7855801A AU2001278558A1 AU 2001278558 A1 AU2001278558 A1 AU 2001278558A1 AU 2001278558 A AU2001278558 A AU 2001278558A AU 7855801 A AU7855801 A AU 7855801A AU 2001278558 A1 AU2001278558 A1 AU 2001278558A1
Authority
AU
Australia
Prior art keywords
bronchi
treating inflammation
upper airways
airways
inflammation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278558A
Inventor
Laurent Lecourt
Marc Lemaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Liquide Sante International SA
Original Assignee
Air Liquide Sante International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Liquide Sante International SA filed Critical Air Liquide Sante International SA
Publication of AU2001278558A1 publication Critical patent/AU2001278558A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001278558A 2000-07-27 2001-07-23 Use of co for treating inflammation of upper airways or bronchi Abandoned AU2001278558A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0009881 2000-07-27
FR0009881A FR2812197B1 (en) 2000-07-27 2000-07-27 USE OF CO IN THE TREATMENT OF INFLAMMATION OF THE UPPER AIRWAYS OR BRONCHIA
PCT/FR2001/002396 WO2002009731A1 (en) 2000-07-27 2001-07-23 Use of co for treating inflammation of upper airways or bronchi

Publications (1)

Publication Number Publication Date
AU2001278558A1 true AU2001278558A1 (en) 2002-02-13

Family

ID=8852996

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278558A Abandoned AU2001278558A1 (en) 2000-07-27 2001-07-23 Use of co for treating inflammation of upper airways or bronchi

Country Status (4)

Country Link
EP (1) EP1307208A1 (en)
AU (1) AU2001278558A1 (en)
FR (1) FR2812197B1 (en)
WO (1) WO2002009731A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
BR0210599A (en) 2001-06-21 2004-07-20 Beth Israel Hospital Use of carbon monoxide, method for maintaining an animal cell in vitro, article of manufacture as well as sterile cell medium
UA86344C2 (en) 2002-02-13 2009-04-27 Бет Ізрейел Діконісс Медікал Сентер, Інк. Normal;heading 1;heading 2;METHOD OF TREATING VASCULAR DISEASE
RS91004A (en) 2002-04-15 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Methods of treating ileus
JP2005522521A (en) 2002-04-15 2005-07-28 ベス イスラエル デアコネス メディカル センター Use of heme oxygenase-1 and heme degradation products
HRP20040973A2 (en) 2002-04-15 2005-06-30 University Of Pittsburgh Of The Commonwealth Syste Method of treating necrotizing enterocolitis
RS99304A (en) 2002-05-17 2007-04-10 Yale University, Methods of treating hepatitis
JP2005533062A (en) * 2002-06-12 2005-11-04 メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Brain protection with xenon-containing gas
JP2005533787A (en) * 2002-06-12 2005-11-10 メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Antispasmodic containing xenon
PL375161A1 (en) * 2002-06-21 2005-11-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
HRP20050389A2 (en) * 2002-11-07 2005-08-31 University Of Pittsburgh Of The Commonwealth Systeyale University Treatment for hemorrhagic shock
FR2849779B1 (en) * 2003-01-15 2006-07-14 Air Liquide Sante Sa USE OF XENON OR N2O IN THE TREATMENT OF POST-ISCHEMIC CEREBRAL CELL DETERIORATIONS
CA2542412A1 (en) * 2003-10-21 2005-05-06 Aga Ab Use of xenon for the prevention of programmed cell death
EP1552840A1 (en) * 2004-01-07 2005-07-13 Aga Ab Use of a xenon/carbon monoxide mixture for the protection of cells
CA2633099C (en) * 2005-12-21 2015-04-21 Uti Limited Partnership Treatment of respiratory diseases
RU2346695C2 (en) * 2006-08-15 2009-02-20 Общество с ограниченной ответственностью "Ксиан"(ООО "Ксиан") Xenon application for correction of organism lesions associated with antioxidant status disorder
FR2956323B1 (en) * 2010-02-15 2013-12-20 Air Liquide ARGON-BASED INHALABLE GAS MEDICINE AGAINST PERIPHERAL ORGAN DEFECTS OR MALFUNCTIONS
FR2960779A1 (en) * 2010-06-08 2011-12-09 Air Liquide INHALABLE GASEOUS MEDICINE BASED ON KRYPTON AGAINST PERIPHERAL ORGAN DEFECTS OR FAILURES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914103B1 (en) * 1996-04-05 2006-06-28 The General Hospital Corporation Treatment of a hemoglobinopathy
DK0921807T3 (en) * 1996-08-27 2004-03-15 Messer Griesheim Gmbh Hydrogen-containing drug

Also Published As

Publication number Publication date
FR2812197B1 (en) 2003-01-03
EP1307208A1 (en) 2003-05-07
FR2812197A1 (en) 2002-02-01
WO2002009731A1 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2001278558A1 (en) Use of co for treating inflammation of upper airways or bronchi
AU2001251136A1 (en) Compositions and methods for promoting wound healing
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2001286983A1 (en) Method of treatment
AU2001269329A1 (en) Method of spray drying
WO2001091700A8 (en) Composition and method for enhancing elasticity of tissue
AU2001293891A1 (en) New combination for the treatment of asthma
AU2002217808A1 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
IL155769A0 (en) Method for the treatment of inflammation
AU2002223544A1 (en) Distribution of content
AU2001292818A1 (en) Use of transcription factors for treating inflammation and other diseases
AU2001293557A1 (en) New inhibitors of iapp fibril formation and uses thereof
AU2001262177A1 (en) Method of treatment
AU2001274004A1 (en) Method for the production of 2- coumarone and substituted 2-coumarones
AU4021700A (en) Methods of use of beta1-integrin inhibitors
AU2001253560A1 (en) Methods of treatment
AU1943501A (en) Methods of treating inflammation and compositions therefor
AU2001277750A1 (en) Use of polypeptide
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2001261785A1 (en) Vdup1 promoter and methods of use thereof
AU2338701A (en) Endoscope and method for use thereof